Management of Hyperglycemia with Low Total Protein and Globulin Levels

Assessment of Hyperglycemia

The American Diabetes Association recommends intervention for persistent hyperglycemia starting at a threshold ≥180 mg/dL, with a target range of 140-180 mg/dL for most patients, and more stringent goals (110-140 mg/dL) may be appropriate for selected patients if achievable without significant hypoglycemia 1
The patient's glucose level of 117 mg/dL is above the normal range (70-99 mg/dL), indicating hyperglycemia 1

Low globulin levels may indicate immune deficiency, protein-losing enteropathy, malnutrition, or liver disease, according to the Journal for ImmunoTherapy of Cancer 2, 4
The patient's total protein (5.3 g/dL) and globulin (1.5 g/dL) levels are below reference ranges (5.9-8.4 g/dL and 1.7-3.7 g/dL, respectively) 2, 3

The American Diabetes Association recommends beginning metformin as first-line therapy if not contraindicated by renal function, starting with a low dose (500 mg daily) and titrating gradually to minimize gastrointestinal side effects 4, 5

The Journal for ImmunoTherapy of Cancer recommends monitoring blood glucose regularly, with frequency determined by severity of hyperglycemia, and following up protein and albumin levels in 4-6 weeks to assess response to interventions 2, 3

The combination of hyperglycemia and low protein/globulin levels may indicate an underlying systemic condition that requires comprehensive evaluation, and consideration of immune checkpoint inhibitor therapy as a potential cause if the patient is undergoing cancer treatment 2, 3
The Journal for ImmunoTherapy of Cancer recommends avoiding SGLT2 inhibitors initially until protein status is clarified, as they may increase risk of infections in immunocompromised patients 2

Delaying treatment of hyperglycemia while investigating protein issues - both should be addressed concurrently, according to the American Diabetes Association 1
Failing to consider drug-drug interactions if multiple medications are prescribed for different conditions, as recommended by the American Diabetes Association 5